Tag: CTA
Bracco, Avicenna.AI announce US FDA clearance for new brain aneurysm detection...
Bracco and Avicenna.AI today announced the US Food and Drug Administration (FDA) 510(k) clearance of UPTUNITY-Aneurysm—the first offering within Bracco’s new UPTUNITY portfolio, and...
AI-enabled NeuroDR software for neurovascular imaging gains US FDA 510(k) clearance
Deep Reasoning AI—a company founded by Cornell University (Ithaca, USA) artificial intelligence (AI) professors—has announced that the US Food and Drug Administration has granted...
Methinks expands stroke detection solution into contrast imaging with second US...
Methinks announced today that it has received US Food and Drug Administration (FDA) 510(k) clearance for Methinks computed tomography angiography (CTA) Stroke, an artificial...
RapidAI secures US FDA 510(k) clearance for “groundbreaking” 3D head and...
RapidAI has received US Food and Drug Administration (FDA) 510(k) clearance for Lumina 3D—an “industry-first”, automated 3D imaging reconstruction solution designed to replace manual...
RAPID CTA gets FDA clearance
iSchemaView has received final clearance from the US Food and Drug Administration (FDA) for RAPID CTA, the company’s 3D imaging solution for Computed Tomography...





